查找临床试验
已按「甲状腺眼病」检索，对应国际通用词 thyroid eye disease
共找到 39 项正在招募的试验（在欧美日韩等发达国家设有中心）
数据更新于 23:03，每 5 分钟自动同步Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
United States
年龄 不限 – 不限
Sanford Health
A Study to Investigate the Efficacy and Safety of Rilzabrutinib in Adult Participants With Graves' Disease
Argentina、Canada、Chile、Germany、Greece 等 9 国
年龄 18 Years – 75 Years
Sanofi
Validating Immunological Markers Associated With Mental Fatigue in Graves' Disease
Sweden
年龄 18 Years – 72 Years
Vastra Gotaland Region
Study to Determine if BHV-1300 is Effective and Safe in Adults With Graves' Disease
United States、Canada、Puerto Rico
年龄 18 Years – 70 Years
Biohaven Therapeutics Ltd.
Study of BHV-1300 in Graves' Disease
United States、Australia
年龄 18 Years – 65 Years
Biohaven Therapeutics Ltd.
Thyroid Artery Goitre Embolization Trial A Pilot Study Investigating Thyroid Artery Embolisation as a Treatment for Large Thyroid Nodules
United Kingdom
年龄 18 Years – 不限
Royal Berkshire NHS Foundation Trust
Preoperative Corticosteroids in Autoimmune Thyroid Disease
United States
年龄 18 Years – 不限
Indiana University
Bimatoprost as a Treatment for Graves' Orbitopathy
United States
年龄 18 Years – 不限
Johns Hopkins University
Evaluation of ETHY-001 for Safety, Tolerability, and Clinical Activity in Thyroid Eye Disease
United States
年龄 18 Years – 不限
Ethyreal Bio, Inc.
DICER1-related Pleuropulmonary Blastoma Cancer Predisposition Syndrome: A Natural History Study
United States
年龄 1 Month – 99 Years
National Cancer Institute (NCI)
Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
United States
年龄 18 Years – 75 Years
Anusha Kalbasi
Describe the Progression of Inflammatory Orbitopathy and the Biological Progression of Patients Receiving Second-line Treatment
France
年龄 18 Years – 不限
Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts